{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prevenar+20", "query": { "intervention": "Prevenar 20" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 70, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prevenar+20&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T19:28:22.322Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07629440", "title": "A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Disease" ], "interventions": [ { "name": "PG4", "type": "BIOLOGICAL" }, { "name": "20-valent pneumococcal conjugate vaccine (20vPnC)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "211 Days", "sex": "ALL", "summary": "42 Days to 211 Days" }, "enrollment_count": 3230, "start_date": "2026-05-29", "completion_date": "2029-06-05", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 79, "location_summary": "Birmingham, Alabama • Centreville, Alabama • Fayetteville, Arkansas + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Centreville", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07629440" }, { "nct_id": "NCT06177912", "title": "A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infection" ], "interventions": [ { "name": "V116", "type": "BIOLOGICAL" }, { "name": "PPSV23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 882, "start_date": "2024-01-18", "completion_date": "2025-02-26", "has_results": true, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Madera, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Madera", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06177912" }, { "nct_id": "NCT06524414", "title": "A Study to Learn About How a New Pneumococcal Vaccine Works in Infants", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Disease" ], "interventions": [ { "name": "PG4", "type": "BIOLOGICAL" }, { "name": "20-valent pneumococcal conjugate vaccine (20vPnC)", "type": "BIOLOGICAL" }, { "name": "15-valent pneumococcal conjugate vaccine (PCV15)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "98 Days", "sex": "ALL", "summary": "42 Days to 98 Days" }, "enrollment_count": 605, "start_date": "2024-07-25", "completion_date": "2027-05-01", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 61, "location_summary": "Fayetteville, Arkansas • Jonesboro, Arkansas • La Puente, California + 39 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "La Puente", "state": "California" }, { "city": "West Covina", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06524414" }, { "nct_id": "NCT07660198", "title": "Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Disease" ], "interventions": [ { "name": "PG4", "type": "BIOLOGICAL" }, { "name": "20-valent pneumococcal conjugate vaccine (20vPnC)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "15 Months to 17 Years" }, "enrollment_count": 1200, "start_date": "2026-06-15", "completion_date": "2027-12-02", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 57, "location_summary": "Birmingham, Alabama • Guntersville, Alabama • Fair Oaks, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" }, { "city": "Fair Oaks", "state": "California" }, { "city": "Ontario", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07660198" }, { "nct_id": "NCT07284654", "title": "Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Vaccines" ], "interventions": [ { "name": "31 valent pneumococcal conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "PCV20", "type": "BIOLOGICAL" }, { "name": "PCV21", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vaxcyte, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4049, "start_date": "2025-12-01", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 30, "location_summary": "Birmingham, Alabama • Chinle, Arizona • Whiteriver, Arizona + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chinle", "state": "Arizona" }, { "city": "Whiteriver", "state": "Arizona" }, { "city": "Riverside", "state": "California" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07284654" }, { "nct_id": "NCT05412030", "title": "A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumonia, Bacterial", "Pneumococcal Infections", "Pneumonia, Pneumococcal" ], "interventions": [ { "name": "AFX3772", "type": "BIOLOGICAL" }, { "name": "Prevnar 13", "type": "BIOLOGICAL" }, { "name": "Prevnar 20", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "90 Days", "sex": "ALL", "summary": "42 Days to 90 Days" }, "enrollment_count": 388, "start_date": "2022-06-16", "completion_date": "2025-09-18", "has_results": false, "last_update_posted_date": "2025-10-21", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 42, "location_summary": "Jonesboro, Arkansas • Los Angeles, California • Miami, Florida + 35 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" }, { "city": "Saint Augustine", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05412030" }, { "nct_id": "NCT04382326", "title": "20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Disease" ], "interventions": [ { "name": "20-valent pneumococcal conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "13-valent pneumococcal conjugate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "98 Days", "sex": "ALL", "summary": "42 Days to 98 Days" }, "enrollment_count": 1997, "start_date": "2020-05-20", "completion_date": "2022-09-02", "has_results": true, "last_update_posted_date": "2023-12-06", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 105, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04382326" }, { "nct_id": "NCT03480763", "title": "A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "V114", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "PNEUMOVAX™23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 652, "start_date": "2018-06-22", "completion_date": "2019-12-23", "has_results": true, "last_update_posted_date": "2021-11-02", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 15, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Spring Valley, California + 12 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Spring Valley", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03480763" }, { "nct_id": "NCT07168915", "title": "A Study of V118E in Healthy Participants (V118E-003)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "V118E", "type": "BIOLOGICAL" }, { "name": "PREVNAR 20™", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 126, "start_date": "2025-10-08", "completion_date": "2027-07-06", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 4, "location_summary": "Hallandale, Florida • South Miami, Florida • Springfield, Missouri + 1 more", "locations": [ { "city": "Hallandale", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07168915" }, { "nct_id": "NCT06740630", "title": "A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chickenpox" ], "interventions": [ { "name": "Investigational varicella vaccine_Lot 1", "type": "BIOLOGICAL" }, { "name": "Investigational varicella vaccine_Lot 2", "type": "BIOLOGICAL" }, { "name": "Investigational varicella vaccine_Lot 3", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine_Lot 1", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine_Lot 2", "type": "BIOLOGICAL" }, { "name": "MMR vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" }, { "name": "PCV (pneumococcal conjugate vaccine) 13", "type": "BIOLOGICAL" }, { "name": "PCV 20", "type": "BIOLOGICAL" }, { "name": "Vaxneuvance", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 1840, "start_date": "2025-01-10", "completion_date": "2027-05-17", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-09-02T19:28:22.322Z", "location_count": 59, "location_summary": "Mobile, Alabama • Hot Springs, Arkansas • Sherwood, Arkansas + 50 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Sherwood", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06740630" } ] }